Table 1.
Demographic characteristics
| Complications Group (n = 82) |
Diabetes Group (n = 85) |
Healthy Control Group(n = 90) | χ2/t | P value | |
|---|---|---|---|---|---|
| Gender (male/female) | 43/39 | 45/40 | 47/43 | 0.009 | 0.996 |
| Age (years) | 55.4 ± 5.2 | 55.9 ± 6.2 | 56.1 ± 6.2 | 0.355 | 0.702 |
| WHR | 1.03 ± 0.03a,b | 0.95 ± 0.05 | 0.91 ± 0.06 | 133.612 | <0.001 |
| BMI (kg/m2) | 25.02 ± 2.28 | 24.79 ± 2.12 | 24.02 ± 2.39 | 0.331 | 0.719 |
| Duration of diabetes (years) | 4.03 ± 0.38 | 3.97 ± 0.41 | – | 0.981 | 0.328 |
| Medications for diabetes and dyslipidemia | 1.428 | 0.629 | |||
| Insulin | 33 (37.80) | 33 (38.82) | |||
| Dimethyldiguanide | 29 (35.37) | 27 (31.76) | |||
| Alpha-glucosidase inhibitor | 15 (18.29) | 28 (32.94) | |||
| Statins | 20 (24.39) | 28 (32.94) |
acompare with Diabetes Group (P<0.05); bcompare with Healthy Control Group (P<0.05); WHR waist hip ratio, BMI body mass index